Next Financial Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $469K | Buy |
2,135
+1,707
| +399% | +$375K | 0.03% | 573 |
|
|
2021
Q3 | $78K | Sell |
428
-2,465
| -85% | -$449K | 0.01% | 1224 |
|
|
2021
Q2 | $583K | Buy |
2,893
+515
| +22% | +$104K | 0.05% | 403 |
|
|
2021
Q1 | $511K | Buy |
2,378
+619
| +35% | +$133K | 0.05% | 413 |
|
|
2020
Q4 | $416K | Buy |
1,759
+176
| +11% | +$41.6K | 0.04% | 439 |
|
|
2020
Q3 | $430K | Sell |
1,583
-37
| -2% | -$10.1K | 0.05% | 364 |
|
|
2020
Q2 | $470K | Sell |
1,620
-14
| -0.9% | -$4.06K | 0.05% | 313 |
|
|
2020
Q1 | $389K | Sell |
1,634
-52
| -3% | -$12.4K | 0.05% | 333 |
|
|
2019
Q4 | $369K | Buy |
1,686
+14
| +0.8% | +$3.06K | 0.04% | 446 |
|
|
2019
Q3 | $283K | Buy |
1,672
+480
| +40% | +$81.2K | 0.03% | 525 |
|
|
2019
Q2 | $219K | Buy |
1,192
+462
| +63% | +$84.9K | 0.02% | 629 |
|
|
2019
Q1 | $134K | Buy |
+730
| New | +$134K | 0.03% | 461 |
|
|
2018
Q4 | – | Sell |
-5
| Closed | -$1K | – | 2122 |
|
|
2018
Q3 | $1K | Buy |
+5
| New | +$1K | ﹤0.01% | 1436 |
|
|
2017
Q4 | – | Sell |
-66
| Closed | -$10K | – | 1401 |
|
|
2017
Q3 | $10K | Buy |
66
+5
| +8% | +$758 | ﹤0.01% | 1228 |
|
|
2017
Q2 | $8K | Sell |
61
-400
| -87% | -$52.5K | ﹤0.01% | 1417 |
|
|
2017
Q1 | $55K | Hold |
461
| – | – | 0.02% | 687 |
|
|
2016
Q4 | $34K | Sell |
461
-100
| -18% | -$7.38K | 0.01% | 1117 |
|
|
2016
Q3 | $49K | Sell |
561
-102
| -15% | -$8.91K | 0.01% | 950 |
|
|
2016
Q2 | $57K | Hold |
663
| – | – | 0.02% | 620 |
|
|
2016
Q1 | $52K | Sell |
663
-150
| -18% | -$11.8K | 0.02% | 611 |
|
|
2015
Q4 | $102K | Hold |
813
| – | – | 0.04% | 416 |
|
|
2015
Q3 | $84K | Hold |
813
| – | – | 0.03% | 483 |
|
|
2015
Q2 | $100K | Hold |
813
| – | – | 0.03% | 467 |
|
|
2015
Q1 | $95K | Sell |
813
-50
| -6% | -$5.84K | 0.03% | 481 |
|
|
2014
Q4 | $103K | Sell |
863
-50
| -5% | -$5.97K | 0.03% | 444 |
|
|
2014
Q3 | $103K | Buy |
+913
| New | +$103K | 0.02% | 649 |
|